Many products require CE marking before they can be sold in the EU. CE marking indicates that a product has been assessed by the manufacturer and deemed to meet EU safety, health and environmental ...

It is an ongoing problem, not a passing one. While there are different types of depression, the most common one is major depressive disorder. It consists of episodes during which the symptoms last ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and anti-anxiety medications in adolescents and young adults has increased sharply since 2001, according to researchers.

Older adults with major depressive disorder (MDD) demonstrate distinct ... from one episode lasting weeks to a lifelong disorder with recurrent major depressive episodes. Depressed individuals ...

Citation: Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment (2025, January 22) retrieved 11 February 2025 from https://medicalxpress.com ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

DTG + 3TC regimen shows high efficacy in viral suppression for both ART-naïve and experienced individuals, with low virologic failure rates. The meta-analysis included 43 studies, confirming ...

An actor who has been making his professional stage debut as Rodney Trotter alongside Paul Whitehouse says he never really felt growing up in a seaside town would lead to an acting career.

Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients. AI's diagnostic accuracy was high for predicting overall survival and no ...

The study used anonymized data from more than five million people. (Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Cell, 2025)"There are huge gaps in our understanding ...